Skip to content

A Study to Check the Effects of Eranda Kshara on Disturbed Lipid Profile

Clinical Evaluation Of Eranda Kshara in Medoroga(Dyslipidemia) - NIL

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/098457
Enrollment
30
Registered
2025-12-04
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E785- Hyperlipidemia, unspecified

Interventions

None listed

Sponsors

saba tyagi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients of age group 30 to 60 years of any gender. 2.Both obese and non obese patients are included with BMI in range 18.50 Kg/m2-40 Kg/m2. 3.Patients presenting symptoms of Medodushti as per Ayurvedic classics such as Chala Sphika Udara Stana,Swedabadha,etc. 4.Patients having one or more than one levels among criteria according to National Cholesterol Eradication Programme ATP III classification. Patients having serum cholesterol level 200 mg/dL -239 mg/dL. Patients having serum LDL level 130 mg/dL -159 mg/dL. Patients having serum VLDL level 40 mg/dL. Patients having serum triglycerides level 150 mg/dL -190 mg/dL.

Exclusion criteria

Exclusion criteria: 1.Patients not willing to give written informed consent. 2.All the patients with lipid profile above the range as mentioned in Inclusion Criteria. 3.Patients having Diabetes mellitus, Hypertension, Hypothyroidism, Coronary Artery Disease and other comorbidities will be excluded from the study. 4.Patients with history of prolonged alcohol consumption. 5.Patients who are on lipid lowering agent. 6.Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
Relief in subjective parameters: 1.Chala Sphika Udara Stana (Movement of Body parts) 2.Swedadikyata (Excessive Sweating) 3.Kshudha Atimatra (Excessive Hunger) 4.Kshudra Shwasa (Shortness of Breath) 5.Atipipasa (Excessive Thirst)Timepoint: Assessment will be done on 0 day(Before treatment),15th day (15 days post commencement of trial),30th day (15 days after 1st assessment),45th day (15 days after 2nd assessment),60th day (15 days after 3rd assessment)

Secondary

MeasureTime frame
Relief in objective criteria 1.Lipid profile- Complete profile including Serum Cholesterol ,Serum Triglycerides,Serum HDL,Serum LDL,Serum VLDL. 2.Fasting blood glucose 3.LFT-Total Serum Bilirubin,SGOT,SGPTTimepoint: Assessment will be done on 0 day(Before treatment),15th day (15 days post commencement of trial),30th day (15 days after 1st assessment),45th day (15 days after 2nd assessment),60th day (15 days after 3rd assessment)

Countries

India

Contacts

Public ContactSaba Tyagi

Quadra Institute of Ayurveda and Hospital

drrajnikant83@gmail.com8054114530

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026